Charles River Laboratories International (CRL) Non-Current Deffered Revenue (2010 - 2011)
Charles River Laboratories International (CRL) posted quarterly Non-Current Deffered Revenue of $25.4 million for Q3 2011, up 1.05% quarter-over-quarter from $25.2 million in Q2 2011.
Charles River Laboratories International (CRL) Non-Current Deffered Revenue (2010 - 2011) Analysis & Trends
Charles River Laboratories International's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $25.4 million for Q3 2011.
- In Q3 2011, Non-Current Deffered Revenue changed N/A year-over-year to $25.4 million; the TTM figure through Sep 2011 stood at $25.4 million (changed N/A YoY), while the FY2010 annual figure was $24.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q3 2011 stood at $25.4 million, up from $25.2 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $25.4 million in Q3 2011, with the low at $24.7 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 32.59 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 24, 2011 | 25.45 Mn |
| Jun 25, 2011 | 25.18 Mn |
| Dec 25, 2010 | 24.66 Mn |